Rice Hall James & Associates LLC Sells 5,013 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Rice Hall James & Associates LLC lessened its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 6.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 73,795 shares of the medical instruments supplier's stock after selling 5,013 shares during the quarter. Rice Hall James & Associates LLC owned approximately 2.25% of Utah Medical Products worth $4,135,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Bessemer Group Inc. acquired a new position in Utah Medical Products during the fourth quarter worth approximately $31,000. Tower Research Capital LLC TRC grew its position in shares of Utah Medical Products by 172.6% in the fourth quarter. Tower Research Capital LLC TRC now owns 518 shares of the medical instruments supplier's stock valued at $32,000 after purchasing an additional 328 shares during the last quarter. Deutsche Bank AG acquired a new position in shares of Utah Medical Products in the fourth quarter valued at approximately $43,000. Golden State Wealth Management LLC grew its position in shares of Utah Medical Products by 100.0% in the first quarter. Golden State Wealth Management LLC now owns 1,000 shares of the medical instruments supplier's stock valued at $56,000 after purchasing an additional 500 shares during the last quarter. Finally, New Age Alpha Advisors LLC acquired a new position in shares of Utah Medical Products in the fourth quarter valued at approximately $101,000. Institutional investors and hedge funds own 69.60% of the company's stock.

Utah Medical Products Stock Up 0.7%

Shares of Utah Medical Products stock traded up $0.38 on Thursday, hitting $56.58. The stock had a trading volume of 3,457 shares, compared to its average volume of 19,530. Utah Medical Products, Inc. has a twelve month low of $51.26 and a twelve month high of $77.33. The business's 50 day moving average is $55.56 and its two-hundred day moving average is $57.16. The stock has a market cap of $183.87 million, a price-to-earnings ratio of 14.97 and a beta of 0.28.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last posted its earnings results on Tuesday, April 29th. The medical instruments supplier reported $0.92 EPS for the quarter. Utah Medical Products had a return on equity of 10.74% and a net margin of 33.00%. The company had revenue of $9.71 million for the quarter.

Utah Medical Products Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, July 3rd. Investors of record on Monday, June 16th were paid a $0.305 dividend. This represents a $1.22 annualized dividend and a dividend yield of 2.16%. The ex-dividend date was Monday, June 16th. Utah Medical Products's dividend payout ratio (DPR) is currently 32.28%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.